Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases

…, B Grange, D Israël-Biet, S Phin-Huynh, C Bron… - Neurology, 2020 - AAN Enterprises
Objectives The predominance of extramuscular manifestations (eg, skin rash, arthralgia,
interstitial lung disease [ILD]) as well as the low frequency of muscle signs in anti–melanoma …

Bcl-2 overexpression in type II epithelial cells does not prevent hyperoxia-induced acute lung injury in mice

…, K Khatib, P Herrera, Y Donati, C Bron… - … of Physiology-Lung …, 2010 - journals.physiology.org
Bcl-2 is an anti-apoptotic molecule preventing oxidative stress damage and cell death. We
have previously shown that Bcl-2 is able to prevent hyperoxia-induced cell death when …

Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy

…, JE Kahn, L Guillevin, E Rivaud, C Bron… - European …, 2015 - Eur Respiratory Soc
The underlying mechanisms of bronchiectasis are poorly understood and the cause remains
unknown in half of the patients [1]. Whether bronchiectasis is the direct consequence of …

Innovative therapeutics for idiopathic pulmonary fibrosis

Y Uzunhan, H Nunes, T Gille, C Bron… - … (Paris, France: 1983), 2011 - europepmc.org
Idiopathic pulmonary fibrosis (IPF), the most common and severe interstitial lung disease,
remains a great challenge for clinicians. The natural history of the disease is incompletely …

Chronic beryllium disease: azathioprine as a possible alternative to corticosteroid treatment

H Salvator, T Gille, A Hervé, C Bron… - European …, 2013 - Eur Respiratory Soc
8 Kieckhefer GM, Lentz MJ, Tsai SY, et al. Parent-child agreement in report of nighttime
respiratory symptoms and sleep disruptions and quality. J Pediatr Health Care 2009; 23: 315–…

Unexpected Pneumocystis jirovecii pneumonia in patients with untreated chronic lymphocytic leukemia

L Sesé, E Rivaud, C Bron, V Leblond… - Leukemia & …, 2018 - Taylor & Francis
Chronic lymphocytic leukemia (CLL) is a common hematological malignancy in adult patients.
Infectious complications are frequently observed [1]. In untreated CLL patients, pulmonary …

Pulmonary non-tuberculous mycobacterial infection in patients without predisposing condition, morphological and immunological overview of a french cohort

E Catherinot, C Bron, J Rosain, V Jeanne-Julien… - 2021 - Eur Respiratory Soc
Introduction: Nontuberculous mycobacteria may cause lung disease (pNTM). pNTM may
present as a pattern of bronchiolar nodules and bronchiectasis (NB), which concerns a majority …

Innovations thérapeutiques de la fibrose pulmonaire idiopathique

Y Uzunhan, H Nunes, T Gille, C Bron, C Planès… - La Presse Médicale, 2011 - Elsevier
Idiopathic pulmonary fibrosis (IPF), the most common and severe interstitial lung disease,
remains a great challenge for clinicians. The natural history of the disease is incompletely …

Supramolecular organization of the yeast F1Fo‐ATP synthase

D Thomas, P Bron, T Weimann, A Dautant… - Biology of the …, 2008 - Wiley Online Library
Background information. The yeast mitochondrial F 1 F o ‐ATP synthase is a large complex
of 600 kDa that uses the proton electrochemical gradient generated by the respiratory chain …

Characteristics of inflammatory bowel diseases-associated interstitial lung diseases

C Bron, M Kambouchner, T Gille, Y Uzunhan… - 2011 - Eur Respiratory Soc
Introduction: Various interstitial lung diseases (ILD) have been reported in inflammatory bowel
diseases (IBD) but most publications are limited to small series or predate the 2002 ATS/…